Biogen - 34 Year Stock Price History | BIIB

Historical daily share price chart and data for Biogen since 1991 adjusted for splits and dividends. The latest closing stock price for Biogen as of July 30, 2025 is 126.64.
  • The all-time high Biogen stock closing price was 475.98 on March 20, 2015.
  • The Biogen 52-week high stock price is 213.50, which is 68.6% above the current share price.
  • The Biogen 52-week low stock price is 110.04, which is 13.1% below the current share price.
  • The average Biogen stock price for the last 52 weeks is 153.48.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 133.1339 150.0000 153.2700 113.3800 126.6400 -17.19%
2024 206.9917 267.7100 267.7100 146.4700 152.9200 -40.91%
2023 271.7870 272.6300 318.0600 222.5900 258.7700 -6.55%
2022 229.2542 244.1400 306.7200 187.5400 276.9200 15.42%
2021 289.5569 242.9500 414.7100 223.9200 239.9200 -2.02%
2020 285.3138 294.2400 355.6300 236.2600 244.8600 -17.48%
2019 263.5519 304.6900 338.9600 216.7100 296.7300 -1.39%
2018 313.6443 334.1700 383.8300 257.5200 300.9200 -5.54%
2017 291.0549 291.7100 344.5800 246.5400 318.5700 12.34%
2016 280.1990 294.6200 330.1100 224.6000 283.5800 -7.43%
2015 352.5856 342.0100 475.9800 256.0400 306.3500 -9.75%
2014 317.9831 280.3300 360.6700 273.5200 339.4500 21.42%
2013 215.2810 150.0000 295.8800 142.8200 279.5700 91.00%
2012 136.5151 113.5000 156.0600 113.5000 146.3700 33.00%
2011 91.9759 67.2000 118.7200 65.0800 110.0500 64.13%
2010 56.3579 53.6400 68.2200 46.2200 67.0500 25.33%
2009 48.9431 48.4900 53.7000 42.1300 53.5000 12.32%
2008 55.4274 55.8700 71.3800 39.0200 47.6300 -16.32%
2007 56.5892 49.3300 82.5100 43.1300 56.9200 15.71%
2006 45.9880 46.7400 52.2600 40.7300 49.1900 8.64%
2005 43.2713 66.2900 67.8000 33.3500 45.2800 -32.02%
2004 57.2481 36.9400 67.9200 36.9400 66.6100 81.50%
2003 34.4312 34.3400 41.5700 28.0900 36.7000 10.64%
2002 47.4686 68.1500 70.9600 30.1500 33.1700 -51.88%
2001 56.9959 59.2500 74.5700 35.6875 68.9300 9.09%
2000 44.2699 31.0833 75.0833 19.1250 63.1875 92.94%
1999 14.0875 7.7917 32.7500 6.8542 32.7500 318.09%
1998 5.4740 5.6458 8.0208 2.9167 7.8333 36.73%
1997 4.6884 3.7500 7.6667 2.7083 5.7292 44.74%
1996 3.7282 3.1875 5.0208 2.4375 3.9583 21.79%
1995 1.1416 0.3958 3.8542 0.3750 3.2500 817.56%
1994 0.5854 0.9375 1.0833 0.3542 0.3542 -63.04%
1993 0.9571 1.5000 1.5000 0.6250 0.9583 -34.29%
1992 1.6281 2.1250 3.3333 1.0417 1.4583 -32.69%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $18.741B $9.676B
Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $229.437B 16.74
Amgen (AMGN) United States $163.226B 14.62
Gilead Sciences (GILD) United States $142.094B 14.76
Vertex Pharmaceuticals (VRTX) United States $120.286B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
CSL (CSLLY) Australia $86.044B 0.00
GSK (GSK) United Kingdom $76.905B 9.23
Regeneron Pharmaceuticals (REGN) United States $60.260B 14.63
Alnylam Pharmaceuticals (ALNY) United States $43.100B 0.00
Argenex SE (ARGX) Netherlands $36.646B 99.80
BioNTech SE (BNTX) Germany $26.799B 0.00
Royalty Pharma (RPRX) United States $20.955B 8.85
Insmed (INSM) United States $19.920B 0.00
Illumina (ILMN) United States $17.209B 32.65
Incyte (INCY) United States $14.977B 19.25
Genmab (GNMSF) Denmark $14.683B 15.02
Genmab (GMAB) Denmark $14.499B 16.26
Moderna (MRNA) United States $12.631B 0.00
QIAGEN (QGEN) Netherlands $11.352B 22.09
BioMarin Pharmaceutical (BMRN) United States $11.167B 18.14
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $9.987B 0.00
Exelixis (EXEL) United States $9.944B 17.93
Bio-Techne Corp (TECH) United States $9.072B 33.84
Exact Sciences (EXAS) United States $8.968B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.953B 0.00
Roivant Sciences (ROIV) United Kingdom $7.763B 0.00
Legend Biotech (LEGN) United States $7.492B 0.00
Halozyme Therapeutics (HALO) United States $7.276B 13.93
Jazz Pharmaceuticals (JAZZ) Ireland $7.056B 6.93
Repligen (RGEN) United States $7.040B 76.87
Revolution Medicines (RVMD) United States $6.894B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.868B 0.00
Anbio Biotechnology (NNNN) Germany $6.779B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Nuvalent (NUVL) United States $5.688B 0.00
TG Therapeutics (TGTX) United States $5.609B 147.21
Rhythm Pharmaceuticals (RYTM) United States $5.448B 0.00
Guardant Health (GH) United States $5.367B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.097B 0.00
Axsome Therapeutics (AXSM) United States $4.944B 0.00
Telix Pharmaceuticals (TLX) Australia $4.565B 0.00
Merus (MRUS) Netherlands $4.563B 0.00
Zai Lab (ZLAB) China $4.500B 0.00
Vaxcyte (PCVX) United States $4.474B 0.00
Alkermes (ALKS) Ireland $4.452B 12.39
Abivax SA (ABVX) France $4.430B 0.00
Krystal Biotech (KRYS) United States $4.395B 33.87
ADMA Biologics Inc (ADMA) United States $4.359B 32.61
Avidity Biosciences (RNA) United States $4.333B 0.00
Cytokinetics (CYTK) United States $4.287B 0.00
PTC Therapeutics (PTCT) United States $3.907B 6.80
Metsera (MTSR) United States $3.905B 0.00
Zealand Pharma (ZLDPF) Denmark $3.878B 0.00
Arcellx (ACLX) United States $3.857B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.787B 33.28
Akero Therapeutics (AKRO) United States $3.786B 0.00
Viking Therapeutics (VKTX) United States $3.701B 0.00
Scholar Rock Holding (SRRK) United States $3.539B 0.00
Ascentage Pharma Group - (AAPG) China $3.497B 0.00
Protagonist Therapeutics (PTGX) United States $3.410B 73.35
MoonLake Immunotherapeutics (MLTX) Switzerland $3.351B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.351B 0.00
Alvotech (ALVO) Luxembourg $2.930B 16.76
Bavarian Nordic (BVNRY) Denmark $2.881B 15.23
Immunovant (IMVT) United States $2.848B 0.00
Kymera Therapeutics (KYMR) United States $2.846B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.615B 0.00
Ligand Pharmaceuticals (LGND) United States $2.539B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.535B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.419B 0.00
Apellis Pharmaceuticals (APLS) United States $2.382B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.369B 0.00
ImmunityBio (IBRX) United States $2.242B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.216B 759.25
Arrowhead Pharmaceuticals (ARWR) United States $2.199B 0.00
Agios Pharmaceuticals (AGIO) United States $2.185B 0.00
IDEAYA Biosciences (IDYA) United States $2.176B 0.00
Twist Bioscience (TWST) United States $2.078B 0.00
Disc Medicine (IRON) United States $2.071B 0.00
Mesoblast (MESO) Australia $2.040B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.036B 13.53
Belite Bio (BLTE) United States $2.025B 0.00
Vericel (VCEL) United States $2.007B 1328.67
Beam Therapeutics (BEAM) United States $2.004B 0.00
CG Oncology (CGON) United States $1.985B 0.00
Denali Therapeutics (DNLI) United States $1.977B 0.00
Amicus Therapeutics (FOLD) United States $1.888B 204.33
Arcutis Biotherapeutics (ARQT) United States $1.787B 0.00
Apogee Therapeutics (APGE) United States $1.747B 0.00
Certara (CERT) United States $1.726B 32.24
Immunocore Holdings (IMCR) United Kingdom $1.703B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.686B 0.00
Liquidia Technologies (LQDA) United States $1.646B 0.00
Adaptive Biotechnologies (ADPT) United States $1.578B 0.00
Sarepta Therapeutics (SRPT) United States $1.556B 0.00
Celcuity (CELC) United States $1.498B 0.00
Edgewise Therapeutics (EWTX) United States $1.468B 0.00
Celldex Therapeutics (CLDX) United States $1.457B 0.00
Janux Therapeutics (JANX) United States $1.430B 0.00
AbCellera Biologics (ABCL) Canada $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.391B 14.33
Travere Therapeutics (TVTX) United States $1.379B 0.00
Viridian Therapeutics (VRDN) United States $1.370B 0.00
Cogent Biosciences (COGT) United States $1.348B 0.00
89BIO (ETNB) United States $1.346B 0.00
Dynavax Technologies (DVAX) United States $1.344B 79.93
Vera Therapeutics (VERA) United States $1.321B 0.00
Biohaven (BHVN) United States $1.310B 0.00
Intellia Therapeutics (NTLA) United States $1.295B 0.00
WAVE Life Sciences (WVE) Singapore $1.294B 0.00
NovoCure (NVCR) Jersey $1.272B 0.00
Cidara Therapeutics (CDTX) United States $1.249B 0.00
GRAIL (GRAL) United States $1.227B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Jyong Biotech (MENS) Taiwan $1.191B 0.00
MannKind (MNKD) United States $1.161B 23.88
Praxis Precision Medicines (PRAX) United States $1.140B 0.00
Novavax (NVAX) United States $1.135B 2.65
Pharvaris (PHVS) Netherlands $1.025B 0.00
Structure Therapeutics (GPCR) United States $1.021B 0.00
Arcus Biosciences (RCUS) United States $1.018B 0.00
Spyre Therapeutics (SYRE) United States $1.011B 0.00
Sana Biotechnology (SANA) United States $1.003B 0.00
Pacira BioSciences (PCRX) United States $1.000B 9.52
MiMedx (MDXG) United States $0.985B 23.82
Iovance Biotherapeutics (IOVA) United States $0.975B 0.00
Anavex Life Sciences (AVXL) United States $0.970B 0.00
Zymeworks (ZYME) United States $0.941B 0.00
Oric Pharmaceuticals (ORIC) United States $0.941B 0.00
Immunome (IMNM) United States $0.922B 0.00
Nurix Therapeutics (NRIX) United States $0.909B 0.00
BGM Group (BGM) China $0.905B 0.00
Mineralys Therapeutics (MLYS) United States $0.905B 0.00
LENZ Therapeutics (LENZ) United States $0.891B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.891B 0.00
Trevi Therapeutics (TRVI) United States $0.886B 0.00
Urogen Pharma (URGN) United States $0.873B 0.00
Nuvation Bio (NUVB) United States $0.837B 0.00
Sionna Therapeutics (SION) United States $0.809B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Immatics (IMTX) Germany $0.806B 0.00
Oculis Holding AG (OCS) Switzerland $0.790B 0.00
CorMedix Inc (CRMD) United States $0.789B 52.91
GH Research (GHRS) Ireland $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Niagen Bioscience (NAGE) United States $0.761B 107.33
Ginkgo Bioworks Holdings (DNA) United States $0.756B 0.00
Upstream Bio (UPB) United States $0.752B 0.00
UniQure (QURE) Netherlands $0.749B 0.00
Vir Biotechnology (VIR) United States $0.726B 0.00
Geron (GERN) United States $0.723B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.709B 0.00
Tango Therapeutics (TNGX) United States $0.700B 0.00
ArriVent BioPharma (AVBP) United States $0.692B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.691B 0.00
Maze Therapeutics (MAZE) United States $0.689B 0.00
Dianthus Therapeutics (DNTH) United States $0.688B 0.00
Gyre Therapeutics (GYRE) United States $0.684B 182.50
Stoke Therapeutics (STOK) United States $0.682B 15.82
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.678B 0.00
NeoGenomics (NEO) United States $0.676B 0.00
Pharming Group (PHAR) Netherlands $0.676B 0.00
Zenas BioPharma (ZBIO) United States $0.671B 0.00
MeiraGTx Holdings (MGTX) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.644B 0.00
Arbutus Biopharma (ABUS) United States $0.632B 0.00
Bicara Therapeutics (BCAX) United States $0.627B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.602B 0.00
Tyra Biosciences (TYRA) United States $0.595B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.590B 0.00
Keros Therapeutics (KROS) United States $0.588B 0.00
Fortrea Holdings (FTRE) United States $0.576B 15.90
Septerna (SEPN) United States $0.568B 0.00
Rapport Therapeutics (RAPP) United States $0.563B 0.00
Kura Oncology (KURA) United States $0.551B 0.00
Solid Biosciences (SLDB) United States $0.548B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.548B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Sage Therapeutics (SAGE) United States $0.545B 0.00
Rezolute (RZLT) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Prime Medicine (PRME) United States $0.515B 0.00
Terns Pharmaceuticals (TERN) United States $0.502B 0.00
MBX Biosciences (MBX) United States $0.500B 0.00
Cullinan Therapeutics (CGEM) United States $0.492B 0.00
Castle Biosciences (CSTL) United States $0.469B 31.82
ATyr Pharma (ATYR) United States $0.467B 0.00
Precigen (PGEN) United States $0.463B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
Cytek Biosciences (CTKB) United States $0.456B 0.00
Gossamer Bio (GOSS) United States $0.446B 0.00
Erasca (ERAS) United States $0.439B 0.00
Compass Therapeutics (CMPX) United States $0.438B 0.00
Kamada (KMDA) Israel $0.432B 25.90
Palvella Therapeutics (PVLA) United States $0.430B 0.00
REGENXBIO (RGNX) United States $0.422B 0.00
Tectonic Therapeutic (TECX) United States $0.417B 0.00
Kodiak Sciences (KOD) United States $0.412B 0.00
Fulcrum Therapeutics (FULC) United States $0.410B 0.00
Eton Pharmaceuticals (ETON) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Myriad Genetics (MYGN) United States $0.378B 0.00
Absci (ABSI) United States $0.376B 0.00
Astria Therapeutics (ATXS) United States $0.375B 0.00
Prothena (PRTA) Ireland $0.373B 0.00
Humacyte (HUMA) United States $0.368B 0.00
Neumora Therapeutics (NMRA) United States $0.354B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.354B 0.00
Emergent Biosolutions (EBS) United States $0.353B 0.00
Inhibrx Biosciences (INBX) United States $0.351B 0.21
Northwest Biotherapeutics (NWBO) United States $0.350B 0.00
Cartesian Therapeutics (RNAC) United States $0.348B 0.00
Verastem (VSTM) United States $0.346B 0.00
Abeona Therapeutics (ABEO) United States $0.345B 0.00
Olema Pharmaceuticals (OLMA) United States $0.343B 0.00
Aura Biosciences (AURA) United States $0.341B 0.00
Candel Therapeutics (CADL) United States $0.329B 0.00
Foghorn Therapeutics (FHTX) United States $0.329B 0.00
Atea Pharmaceuticals (AVIR) United States $0.325B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Rocket Pharmaceuticals (RCKT) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.317B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.308B 0.00
Allogene Therapeutics (ALLO) United States $0.306B 0.00
Amarin (AMRN) Ireland $0.303B 0.00
Inventiva S.A (IVA) France $0.301B 0.00
Ocugen (OCGN) United States $0.301B 0.00
Neurogene (NGNE) United States $0.300B 0.00
Vor Biopharma (VOR) $0.294B 0.00
Replimune (REPL) United States $0.292B 0.00
Benitec Biopharma (BNTC) United States $0.290B 0.00
ScPharmaceuticals (SCPH) United States $0.288B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.287B 0.00
Sagimet Biosciences (SGMT) United States $0.284B 0.00
Aardvark Therapeutics (AARD) United States $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.276B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Lifecore Biomedical (LFCR) United States $0.267B 0.00
Monopar Therapeutics (MNPR) United States $0.263B 0.00
Annexon (ANNX) United States $0.261B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.259B 0.00
Prima BioMed (IMMP) Australia $0.257B 0.00
Alpha Teknova (TKNO) United States $0.256B 0.00
Bright Minds Biosciences (DRUG) United States $0.245B 0.00
Tvardi Therapeutics (TVRD) United States $0.243B 0.00
Third Harmonic Bio (THRD) United States $0.243B 0.00
Crescent Biopharma (CBIO) United States $0.240B 0.00
Entrada Therapeutics (TRDA) United States $0.239B 7.77
Adherex Technologies (FENC) United States $0.237B 0.00
AC Immune (ACIU) Switzerland $0.236B 0.00
Codexis (CDXS) United States $0.234B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.230B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.229B 0.00
Design Therapeutics (DSGN) United States $0.226B 0.00
MaxCyte (MXCT) United States $0.226B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.225B 0.00
Cardiff Oncology (CRDF) United States $0.220B 0.00
Editas Medicine (EDIT) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Alumis (ALMS) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
DiaMedica Therapeutics (DMAC) United States $0.197B 0.00
Semper Paratus Acquisition (TVGN) United States $0.191B 0.00
Rapt Therapeutics (RAPT) United States $0.191B 0.00
BioStem Technologies (BSEM) $0.190B 7.73
Ventyx Biosciences (VTYX) United States $0.190B 0.00
Instil Bio (TIL) United States $0.185B 0.00
Caribou Biosciences (CRBU) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.181B 0.00
CytomX Therapeutics (CTMX) United States $0.181B 4.69
Voyager Therapeutics (VYGR) United States $0.177B 0.00
EnGene Holdings (ENGN) Canada $0.176B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.173B 0.00
SELLAS Life Sciences (SLS) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.166B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.163B 0.00
Elicio Therapeutics (ELTX) United States $0.162B 0.00
Citius Oncology (CTOR) United States $0.161B 0.00
Agenus (AGEN) United States $0.161B 0.00
Alector (ALEC) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
C4 Therapeutics (CCCC) United States $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.159B 0.00
Black Diamond Therapeutics (BDTX) United States $0.158B 46.33
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.158B 4.13
Cellectis S.A (CLLS) France $0.156B 0.00
Greenwich LifeSciences (GLSI) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.148B 0.00
Nkarta (NKTX) United States $0.146B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
IO Biotech (IOBT) Denmark $0.144B 0.00
Actuate Therapeutics (ACTU) United States $0.139B 0.00
I-Mab (IMAB) United States $0.139B 0.00
Contineum Therapeutics (CTNM) United States $0.135B 0.00
Fate Therapeutics (FATE) United States $0.134B 0.00
Genelux (GNLX) United States $0.134B 0.00
Sangamo Therapeutics (SGMO) United States $0.133B 0.00
Immuneering (IMRX) United States $0.132B 0.00
Compugen (CGEN) Israel $0.132B 0.00
23andMe Holding (MEHCQ) United States $0.131B 0.00
Seer (SEER) United States $0.128B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.126B 0.00
BioHarvest Sciences (BHST) Canada $0.124B 0.00
Spero Therapeutics (SPRO) United States $0.123B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Coherus Oncology (CHRS) United States $0.117B 0.00
TuHURA Biosciences (HURA) United States $0.117B 0.00
Tenaya Therapeutics (TNYA) United States $0.115B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
Scilex Holding (SCLX) United States $0.111B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
Seres Therapeutics (MCRB) United States $0.106B 0.00
HilleVax (HLVX) United States $0.106B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Climb Bio (CLYM) United States $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Zura Bio (ZURA) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Oncolytics Biotech (ONCY) Canada $0.099B 0.00
Connect Biopharma Holdings (CNTB) United States $0.097B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.097B 0.00
Invivyd (IVVD) United States $0.097B 0.00
OKYO Pharma (OKYO) $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Immunic (IMUX) United States $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Entera Bio (ENTX) Israel $0.092B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
VistaGen Therapeutics (VTGN) United States $0.089B 0.00
XBiotech (XBIT) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Whitehawk Therapeutics (WHWK) United States $0.083B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
Cabaletta Bio (CABA) United States $0.080B 0.00
TELA Bio (TELA) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Celularity (CELU) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
Elutia (ELUT) United States $0.076B 0.00
Immix Biopharma (IMMX) United States $0.075B 0.00
INmune Bio (INMB) United States $0.075B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
Artiva Biotherapeutics (ARTV) United States $0.071B 0.00
Forte Biosciences (FBRX) United States $0.070B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Opus Genetics (IRD) United States $0.068B 0.00
Genenta Science S.p.A (GNTA) Italy $0.068B 0.00
MiNK Therapeutics (INKT) United States $0.067B 0.00
Oncobiologics (OTLK) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.065B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Applied Therapeutics (APLT) United States $0.063B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Cue Biopharma (CUE) United States $0.062B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.062B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
KALA BIO (KALA) United States $0.054B 0.00
CalciMedica (CALC) United States $0.053B 0.00
Adlai Nortye (ANL) Cayman Islands $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
PDS Biotechnology (PDSB) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
ABVC BioPharma (ABVC) United States $0.051B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Alterity Therapeutics - (ATHE) Australia $0.047B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
PepGen (PEPG) United States $0.045B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
Exicure (XCUR) United States $0.042B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Cognition Therapeutics (CGTX) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Shattuck Labs (STTK) United States $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.039B 0.00
Ovid Therapeutics (OVID) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.038B 0.00
Clearside Biomedical (CLSD) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Dyadic (DYAI) United States $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Mersana Therapeutics (MRSN) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
CAMP4 Therapeutics (CAMP) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.028B 0.00
Clene (CLNN) United States $0.028B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.025B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Aytu BioPharma (AYTU) United States $0.023B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
BioAtla (BCAB) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Rallybio (RLYB) United States $0.020B 0.00
180 Life Sciences (ATNF) United States $0.019B 0.00
Curis (CRIS) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Equillium (EQ) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
MetaVia (MTVA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Advanced Biomed (ADVB) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IBio (IBIO) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00